# Evaluate the Efficacy of Selenium for the Prevention of Chemotherapy-induced Mucositis During Autologous Stem Cell Transplantation.

> **NCT04080622** · PHASE3 · COMPLETED · sponsor: **University Hospital, Angers** · enrollment: 100 (actual)

## Conditions studied

- Mucositis Oral
- Stem Cell Transplant Complications

## Interventions

- **DRUG:** Selenium
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04080622
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-10
- **Primary completion:** 2023-10-08
- **Final completion:** 2023-10-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04080622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04080622, "Evaluate the Efficacy of Selenium for the Prevention of Chemotherapy-induced Mucositis During Autologous Stem Cell Transplantation.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04080622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*